Stock Rating Upgrade
The Value Trend Rating for Quest Diagnostics Inc (NYSE: DGX) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Quest Diagnostics Inc (NYSE: DGX) stock closed at $124.68 on 3/1/24 after a slight decline of -0.2%. NORMAL trading volume accompanied the decline. The stock has declined -0.5% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, DGX is expected to continue to be an important Value Builder.
Quest Diagnostics has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Quest Diagnostics has a neutral Appreciation Score of 59 and a slightly negative Power Rating of 36, leading to the Low Neutral Value Trend Rating.
Be the first to comment